The global layout will further promote Sannuo Bio-CGM products to enter the European market. Recently, Sannuo Bio-CGM has reached a strategic cooperation with A.Menarini Diagnostics, a leading European medical diagnosis company, and signed an exclusive distribution agreement. The continuous glucose monitoring (CGM) products of Sannuo Bio will be launched in the European market in the form of joint brands of both parties. Sannuo Bio authorized A.Menarini Diagnostics to exclusively sell its CGM products in more than 20 countries and regions in Europe. In the future, the latter will vigorously promote the access, promotion and sales of Sannuo Bio CGM products in the European medical insurance market. Sannuo Bio has been actively deploying its internationalization strategy since its listing, and its iCan CGM is the first continuous glucose monitoring product certified by CE MDR in China. At present, Europe is the second largest market for CGM. In this cooperation, the two sides signed an exclusive distribution contract with considerable volume, which is expected to greatly accelerate the penetration and coverage of Sannuo Bio-CGM products in the European market.An increase of 91.3%! In the first 11 months, there were more than 33.1 million people entering and leaving Shanghai port. Since last year, China has successively introduced or resumed various visa-free policies, and the level of entry and exit facilitation has been continuously improved. From January to November this year, Shanghai Border Inspection Station inspected 247,000 inbound and outbound means of transport at Shanghai Port, and inspected more than 33.1 million passengers, up 43.6% and 91.3% respectively over the same period last year. (CCTV News)Jundingda: The opening ceremony of the Mexican subsidiary was held in late November, which will not have a significant impact on the company's revenue for the time being. Jundingda (301538) said in an institutional investigation on December 10 that the Mexican subsidiary had held its opening ceremony in late November 2024, and some downstream customers still need to complete on-site certification and audit. The operating area of the subsidiary is about 6,000 square meters, which will not have a significant impact on the company's operating income for the time being. In the future, the company will explore the feasibility of setting up foreign factories, sales offices and warehouses covering other overseas regions, such as Europe and Southeast Asia, according to the needs of downstream customers.
Alibaba Cloud will build new data centers in five overseas countries. On December 11th, Yuan Qian, president of Alibaba Cloud Intelligent International, revealed that in the next three years, Alibaba Cloud will invest in new data centers in five countries around the world, which are located in South Korea, Malaysia, the Philippines, Thailand and Mexico, and will further increase localized services and ecosystem construction. At present, Alibaba Cloud operates 85 available zones in 28 regions around the world, covering Chinese mainland, Hongkong, Southeast Asia, Japan and South Korea, the Middle East and Europe and America.The number of users of WeChat applet has reached 949 million. According to the latest data of QuestMobile, as of October this year, the cumulative number of users of WeChat applet has reached 949 million. On average, each user spends 1.7 hours a month using WeChat applets, while the average number of uses per month is close to 70, up by 15.1% and 5.2% respectively compared with the same period last year.Hong Kong stocks continued to fall in the afternoon, and the Hang Seng Science and Technology Index fell by 1%, which once rose by more than 1%. The Hang Seng Index fell 0.5%.
Spot gold rebounded more than $7 in the short term and is now reported at $2,683.07 per ounce.Australia's S&P/ASX200 index closed down 39.40 points, or 0.47%, at 8353.60 points on Wednesday, December 11th.The global layout will further promote Sannuo Bio-CGM products to enter the European market. Recently, Sannuo Bio-CGM has reached a strategic cooperation with A.Menarini Diagnostics, a leading European medical diagnosis company, and signed an exclusive distribution agreement. The continuous glucose monitoring (CGM) products of Sannuo Bio will be launched in the European market in the form of joint brands of both parties. Sannuo Bio authorized A.Menarini Diagnostics to exclusively sell its CGM products in more than 20 countries and regions in Europe. In the future, the latter will vigorously promote the access, promotion and sales of Sannuo Bio CGM products in the European medical insurance market. Sannuo Bio has been actively deploying its internationalization strategy since its listing, and its iCan CGM is the first continuous glucose monitoring product certified by CE MDR in China. At present, Europe is the second largest market for CGM. In this cooperation, the two sides signed an exclusive distribution contract with considerable volume, which is expected to greatly accelerate the penetration and coverage of Sannuo Bio-CGM products in the European market.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14